Agilent Technologies (NYSE:A) Releases FY 2025 Earnings Guidance

Agilent Technologies (NYSE:A - Get Free Report) issued an update on its FY 2025 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 5.540-5.610 for the period. The company issued revenue guidance of $6.7 billion-$6.8 billion. Agilent Technologies also updated its Q3 2025 guidance to 1.350-1.370 EPS.

Agilent Technologies Trading Down 1.3%

Shares of NYSE:A traded down $1.45 during mid-day trading on Friday, reaching $111.83. 4,751,122 shares of the company's stock were exchanged, compared to its average volume of 1,929,518. The business's fifty day moving average price is $108.44 and its 200-day moving average price is $126.41. Agilent Technologies has a twelve month low of $96.43 and a twelve month high of $153.84. The firm has a market capitalization of $31.88 billion, a price-to-earnings ratio of 27.61, a PEG ratio of 3.17 and a beta of 1.27. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.66 and a current ratio of 2.09.

Agilent Technologies (NYSE:A - Get Free Report) last posted its quarterly earnings data on Wednesday, May 28th. The medical research company reported $1.31 earnings per share for the quarter, topping the consensus estimate of $1.26 by $0.05. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The company had revenue of $1.67 billion during the quarter, compared to analysts' expectations of $1.63 billion. During the same period in the prior year, the company posted $1.22 earnings per share. Agilent Technologies's revenue for the quarter was up 6.0% compared to the same quarter last year. On average, research analysts predict that Agilent Technologies will post 5.58 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 23rd. Investors of record on Tuesday, July 1st will be paid a dividend of $0.248 per share. The ex-dividend date is Tuesday, July 1st. This represents a $0.99 annualized dividend and a yield of 0.89%. Agilent Technologies's dividend payout ratio is currently 24.44%.

Analyst Ratings Changes

A has been the topic of a number of research analyst reports. UBS Group cut their price target on Agilent Technologies from $150.00 to $130.00 and set a "neutral" rating on the stock in a report on Thursday. TD Cowen increased their target price on shares of Agilent Technologies to $150.00 and gave the stock a "buy" rating in a research note on Thursday. Robert W. Baird reduced their price target on shares of Agilent Technologies from $159.00 to $140.00 and set an "outperform" rating for the company in a report on Thursday, May 22nd. JPMorgan Chase & Co. dropped their price objective on shares of Agilent Technologies from $160.00 to $155.00 and set an "overweight" rating on the stock in a report on Thursday. Finally, Jefferies Financial Group cut their price objective on shares of Agilent Technologies from $135.00 to $116.00 and set a "hold" rating on the stock in a research report on Monday, April 21st. Seven equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company's stock. Based on data from MarketBeat, Agilent Technologies has a consensus rating of "Moderate Buy" and a consensus price target of $140.15.

Insider Activity at Agilent Technologies

In other news, VP Rodney Gonsalves sold 1,908 shares of the company's stock in a transaction on Monday, March 17th. The shares were sold at an average price of $121.98, for a total value of $232,737.84. Following the completion of the sale, the vice president now owns 21,786 shares in the company, valued at $2,657,456.28. This represents a 8.05% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, Director Daniel K. Podolsky sold 1,819 shares of the firm's stock in a transaction dated Monday, March 31st. The shares were sold at an average price of $116.46, for a total transaction of $211,840.74. Following the transaction, the director now directly owns 35,737 shares in the company, valued at $4,161,931.02. The trade was a 4.84% decrease in their ownership of the stock. The disclosure for this sale can be found here.

Hedge Funds Weigh In On Agilent Technologies

A number of hedge funds and other institutional investors have recently modified their holdings of A. Geneos Wealth Management Inc. boosted its holdings in shares of Agilent Technologies by 54.8% in the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company's stock worth $70,000 after buying an additional 212 shares during the last quarter. Brighton Jones LLC raised its position in Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company's stock worth $626,000 after acquiring an additional 270 shares during the period. Acadian Asset Management LLC raised its position in Agilent Technologies by 16.5% in the first quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company's stock worth $625,000 after acquiring an additional 758 shares during the period. Finally, Jones Financial Companies Lllp boosted its stake in Agilent Technologies by 15.9% in the first quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company's stock valued at $602,000 after acquiring an additional 769 shares during the last quarter.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.